lutetium has been researched along with Leiomyosarcoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jüptner, M; Lützen, U; Marx, M; Zuhayra, M | 1 |
1 other study(ies) available for lutetium and Leiomyosarcoma
| Article | Year |
|---|---|
Experimental 177Lu-PSMA-617 radioligand therapy in a patient with extended metastasized leiomyosarcoma.
Topics: Dipeptides; Female; Heterocyclic Compounds, 1-Ring; Humans; Leiomyosarcoma; Ligands; Lutetium; Middle Aged; Neoplasm Metastasis; Prostate-Specific Antigen | 2019 |